DK162985C - Pyridazinderivater, som i 3-stillingen er substitueret med amino, og som indvirker paa centralnervesystemet, fremgangsmaade til fremstilling heraf og laegemidler med indhold heraf - Google Patents

Pyridazinderivater, som i 3-stillingen er substitueret med amino, og som indvirker paa centralnervesystemet, fremgangsmaade til fremstilling heraf og laegemidler med indhold heraf

Info

Publication number
DK162985C
DK162985C DK038984A DK38984A DK162985C DK 162985 C DK162985 C DK 162985C DK 038984 A DK038984 A DK 038984A DK 38984 A DK38984 A DK 38984A DK 162985 C DK162985 C DK 162985C
Authority
DK
Denmark
Prior art keywords
affecting
procedures
amino
manufacturing
nervous system
Prior art date
Application number
DK038984A
Other languages
Danish (da)
English (en)
Other versions
DK162985B (da
DK38984A (da
DK38984D0 (da
Inventor
Jean-Pierre Chambon
Kathleen Biziere
Camille-Georges Wermuth
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of DK38984D0 publication Critical patent/DK38984D0/da
Publication of DK38984A publication Critical patent/DK38984A/da
Publication of DK162985B publication Critical patent/DK162985B/da
Application granted granted Critical
Publication of DK162985C publication Critical patent/DK162985C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK038984A 1983-01-27 1984-01-27 Pyridazinderivater, som i 3-stillingen er substitueret med amino, og som indvirker paa centralnervesystemet, fremgangsmaade til fremstilling heraf og laegemidler med indhold heraf DK162985C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8301234 1983-01-27
FR8301234A FR2540113A1 (fr) 1983-01-27 1983-01-27 Acides derives de la pyridazine actifs sur le systeme nerveux central

Publications (4)

Publication Number Publication Date
DK38984D0 DK38984D0 (da) 1984-01-27
DK38984A DK38984A (da) 1984-07-28
DK162985B DK162985B (da) 1992-01-06
DK162985C true DK162985C (da) 1992-06-01

Family

ID=9285330

Family Applications (1)

Application Number Title Priority Date Filing Date
DK038984A DK162985C (da) 1983-01-27 1984-01-27 Pyridazinderivater, som i 3-stillingen er substitueret med amino, og som indvirker paa centralnervesystemet, fremgangsmaade til fremstilling heraf og laegemidler med indhold heraf

Country Status (27)

Country Link
US (1) US4721711A (enExample)
EP (1) EP0117779B1 (enExample)
JP (1) JPS59141564A (enExample)
KR (1) KR910000638B1 (enExample)
AR (1) AR240045A1 (enExample)
AT (1) ATE48417T1 (enExample)
AU (2) AU2372984A (enExample)
CA (1) CA1238637A (enExample)
DD (1) DD220026A5 (enExample)
DE (1) DE3480653D1 (enExample)
DK (1) DK162985C (enExample)
ES (1) ES529081A0 (enExample)
FI (1) FI78691C (enExample)
FR (1) FR2540113A1 (enExample)
HU (1) HU193890B (enExample)
IE (1) IE57054B1 (enExample)
IL (1) IL70756A (enExample)
MA (1) MA20018A1 (enExample)
NO (1) NO840313L (enExample)
NZ (1) NZ206945A (enExample)
OA (1) OA07644A (enExample)
PH (1) PH21162A (enExample)
PL (1) PL142340B1 (enExample)
PT (1) PT77993B (enExample)
SG (1) SG93690G (enExample)
YU (1) YU14284A (enExample)
ZA (1) ZA84502B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2540113A1 (fr) * 1983-01-27 1984-08-03 Sanofi Sa Acides derives de la pyridazine actifs sur le systeme nerveux central
EP0190563B1 (de) * 1985-01-14 1989-08-02 Boehringer Ingelheim Kg Neue 12-Amino-pyridazino[4',5':3,4]pyrrolo-[2,1-a]isochinoline, Verfahren zu ihrer Herstellung und ihre Verwendung
US5082939A (en) * 1987-01-08 1992-01-21 I.S.F. Societa Per Azioni Pyridazine derivatives
US5106973A (en) * 1987-11-23 1992-04-21 Janssen Pharmaceutica N.V. Pyridzainamine derivatives
US5631255A (en) * 1989-02-07 1997-05-20 Sanofi Pyridazine derivatives
FR2663326B2 (fr) * 1989-11-17 1992-10-16 Sanofi Sa Derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant.
FR2668151A1 (fr) * 1990-10-23 1992-04-24 Rhone Poulenc Agrochimie Composes a groupe triazolopyridazine leurs preparations et compositions herbicides les contenant.
FR2676444B1 (fr) * 1991-05-16 1995-03-10 Sanofi Elf Nouveaux derives d'amino-3 pyridazines actifs sur le systeme nerveux central, procede de preparation et compositions pharmaceutiques en contenant.
CN1038249C (zh) * 1991-08-28 1998-05-06 罗姆和哈斯公司 含有二氢哒嗪酮及其相关化合物的杀菌组合物
US20100210590A1 (en) * 1995-09-27 2010-08-19 Northwestern University Compositions and treatments for seizure-related disorders
US20030176437A1 (en) * 2001-08-31 2003-09-18 D.M. Watterson Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death
EP1812408B1 (en) 2004-11-02 2013-10-09 Northwestern University Pyridazine compounds, compositions and methods
WO2006050359A2 (en) * 2004-11-02 2006-05-11 Northwestern University Pyridazine compounds and methods
WO2007127448A2 (en) * 2006-04-28 2007-11-08 Northwestern University Salts of pyridazine compounds
BRPI0710938A2 (pt) * 2006-04-28 2012-06-26 Univ Northwestern formulações contendo compostos de piridazina para o tratamento de doenças neuroinflamatórias
WO2007127474A2 (en) * 2006-04-28 2007-11-08 Northwestern University Compositions and treatments using pyridazine compounds and cholinesterase inhibitors
US8283351B2 (en) * 2007-04-02 2012-10-09 Institute For Oneworld Health Cyclic and acyclic hydrazine derivatives compositions including them and uses thereof
WO2009131958A2 (en) * 2008-04-21 2009-10-29 Institute For Oneworld Health Compounds, compositions and methods comprising triazine derivatives
US8236838B2 (en) * 2008-04-21 2012-08-07 Institute For Oneworld Health Compounds, compositions and methods comprising isoxazole derivatives
WO2009131957A2 (en) 2008-04-21 2009-10-29 Institute For Oneworld Health Compounds, compositions and methods comprising oxadiazole derivatives
US20090270398A1 (en) * 2008-04-21 2009-10-29 Institute For Oneworld Health Compounds, Compositions and Methods Comprising Pyridazine Derivatives
WO2010033626A1 (en) * 2008-09-19 2010-03-25 Institute For Oneworld Health Compounds, compositions and methods comprising imidazole and triazole derivatives
US8343976B2 (en) * 2009-04-20 2013-01-01 Institute For Oneworld Health Compounds, compositions and methods comprising pyrazole derivatives
US20100267706A1 (en) * 2009-04-20 2010-10-21 Institute For Oneworld Health Compounds, Compositions and Methods Comprising Pyridazine Derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2510998B1 (fr) * 1981-08-07 1986-01-10 Sanofi Sa Nouveaux derives amines de la pyridazine, leur procede de preparation et les medicaments, a action desinhibitrice, qui en comportent
FR2510997A1 (fr) * 1981-08-10 1983-02-11 Sanofi Sa Nouveaux derives de la methyl-4 phenyl-6 pyridazine, procede pour leur preparation et medicaments actifs sur le systeme nerveux central en contenant
FR2540113A1 (fr) * 1983-01-27 1984-08-03 Sanofi Sa Acides derives de la pyridazine actifs sur le systeme nerveux central
US4565814A (en) * 1983-01-28 1986-01-21 Sanofi Pyridazine derivatives having a psychotropic action and compositions

Also Published As

Publication number Publication date
EP0117779A1 (fr) 1984-09-05
JPS59141564A (ja) 1984-08-14
YU14284A (en) 1986-12-31
ES8500243A1 (es) 1984-10-01
FI78691C (fi) 1989-09-11
FI840323L (fi) 1984-07-28
DK162985B (da) 1992-01-06
DE3480653D1 (de) 1990-01-11
IL70756A (en) 1987-03-31
FR2540113A1 (fr) 1984-08-03
DD220026A5 (de) 1985-03-20
NZ206945A (en) 1987-07-31
FI840323A0 (fi) 1984-01-26
DK38984A (da) 1984-07-28
AR240045A1 (es) 1990-01-31
NO840313L (no) 1984-07-30
US4721711A (en) 1988-01-26
ZA84502B (en) 1984-09-26
CA1238637A (en) 1988-06-28
FI78691B (fi) 1989-05-31
PL245931A1 (en) 1985-07-16
AU2142188A (en) 1989-03-16
AU2372984A (en) 1984-08-02
ES529081A0 (es) 1984-10-01
IL70756A0 (en) 1984-04-30
ATE48417T1 (de) 1989-12-15
SG93690G (en) 1991-01-18
KR840007586A (ko) 1984-12-08
EP0117779B1 (fr) 1989-12-06
AU652118B2 (en) 1994-08-18
FR2540113B1 (enExample) 1985-05-17
HU193890B (en) 1987-12-28
PT77993B (fr) 1986-04-10
KR910000638B1 (ko) 1991-01-31
PL142340B1 (en) 1987-10-31
OA07644A (fr) 1985-05-23
PH21162A (en) 1987-08-05
DK38984D0 (da) 1984-01-27
IE840149L (en) 1984-07-27
PT77993A (fr) 1984-02-01
MA20018A1 (fr) 1984-10-01
IE57054B1 (en) 1992-04-08

Similar Documents

Publication Publication Date Title
DK38984D0 (da) Pyridazinderivater, som i 3-stillingen er substitueret med amino, og som indvirker pa centralnervesystemet, fremgangsmade til fremstilling heraf og laegemidler med indhold heraf
DK495585D0 (da) Farmaceutisk praeparat med kontrolleret frigivelse og fremgangsmaade til fremstilling af samme
EP0201741A3 (en) Dipeptide derivatives, processes for preparing them, pharmaceutical composition and use
EP0261977A3 (en) Catechol derivatives, and preventive and remedial preparations for regressive disorders in the central nervous system
FI842459A7 (fi) Tetrahydropyridatsinonijohdannaisia, menetelmiä niiden valmistamiseksi sekä niiden käyttö.
DK212784A (da) Ergolinderivater, fremgangsmaade til deres fremstilling og farmaceutiske midler med indhold heraf
ZA842695B (en) Triazine derivatives,processes for preparation thereof and pharmaceutical compositions comprising the same
FI850266A7 (fi) Atsolyyliaryylialkanolijohdoksia, menetelmä niiden valmistamiseksi ja niiden käyttö.
DK136784D0 (da) Pyrazolo(1,5-a)pyridinderivater samt fremgangsmaade til fremstilling deraf
NO890330D0 (no) Fremgangsmaate til fremstilling av forbindelser med psykotrop virkning.
DK617684D0 (da) 1,3-dioxolanylderivater, fremgangsmaade til deres fremstilling, deres anvendelse og laegemidler indeholdende disse forbindelser
DK581183A (da) 2-azabicyclo(2.2.1)heptan-derivater, fremgangsmaader til deres fremstilling, midler indeholdende disse derivater og deres anvendelse, samt 2-azabicyclo(2.2.1)heptan-derivater som mellemprodukter samt fremgangsmaader til deres fremstilling
DK136684A (da) Pyrazolo(1,5-a)pyridinderivater samt fremgangsmaade til fremstilling deraf
ZA847781B (en) Fluoralkylated carbapeneme derivatives,processes for the production and their use
ZM5086A1 (en) New benzamides,process for their application in the pharmaceutical field
ZA844618B (en) Tetrahydropyridazinone derivatives,processes for their preparation and their use
DK624288D0 (da) 3-substituerede pyridiner, fremgangsmaader til deres fremstilling samt deres anvendelse
DE3479888D1 (en) Furyloxazolylacetic acid derivative, processes for preparing same and pharmaceutical composition
DK160827C (da) Pteridinderivater, fremgangsmaade til fremstilling heraf samt farmaceutisk praeparat
DK166273C (da) Dialkanoyloxybenzyliden-dialkanoat, fremgangsmaade til fremstilling deraf samt farmaceutisk middel indeholdende dette
NO170478C (no) Fremgangsmaate for nedsettelse av klumpdannelsestendensen i gjoedningsmidler, og gjoedningsmiddel med nedsatt klumpdannelsestendens
DE3673544D1 (de) 3-nitropyridinderivate, verfahren zu deren herstellung und diese enthaltende arzneimittel.
DK550383A (da) Perfluorcarbonemulsioner, fremgangsmaade til fremstilling heraf og deres anvendelse som laegemidler
NO910903L (no) Orale farmasoeytiske preparater med selektiv frigjoering i tykktarmen.
GR80576B (en) Thiazine derivatives, process for preparation thereof and pharmaceutical composition comprising the same